1 Anderer U,Nohren H,Koch I,et al.Organization of the pediatric tumor cell bank of the society of pediatric oncology and hematology(GPOH)[J].Klin Padiatr,1998,210(1):1-9. 2 Goda AE,Yoshida T,Horinaka M,et al.Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole[J].Oncogene,2008,27(24):3435-3445. 3 Tardito S,Uggeri J,Bozzetti C,et al.The inhibition of glutamine synthetase sensitizes human sarcoma cells to L-asparaginase[J].Cancer Chemoth Pharm,2007,60(5):751-758. 4 Deberardinis RJ,Lum JJ,Hatzivassiliou G,et al.The biology of cancer:metabolic reprogramming fuels cell growth and proliferation[J].Cell Metab,2008,7(1):11-20. 5 Haigis MC,Mostoslavsky R,Haigis KM,et al.SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells[J].Cell,2006,126(5):941-954. 6 Jeong SM,Xiao C,Finley LW,et al.SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism[J].Cancer Cell,2013,23(4):450-463. 7 Csibi A,Fendt SM,Li C,et al.The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4[J].Cell,2013,153(4):840-854. 8 Ozturk AK,Gokaslan ZL,Wolinsky JP.Surgical treatment of sarcomas of the spine[J].Curr Treat Options Oncol,2014,15(3):482-492. 9 Liu T,Zhang X,Shang M,et al.Dysregulated expression of Slug,vimentin,and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer[J].J Surg Oncol,2013,107(2):188-194. 10 Sebastian C,Satterstrom FK,Haigis MC,et al.From sirtuin biology to human diseases:an update[J].J Biol Chem,2012,287(51):42444-42452. 11 Fernandez-Marcos PJ,Serrano M.Sirt4:the glutamine gatekeeper[J].Cancer Cell,2013,23(4):427-428. 12 Tennant DA,Duran RV,Gottlieb E.Targeting metabolic transformation for cancer therapy[J].Nat Rev Cancer,2010,10(4):267-277. 13 Wise DR,Thompson CB.Glutamine addiction:a new therapeutic target in cancer[J].Trends Biochem Sci,2010,35(8):427-433. 14 Olsen RR,Mary-Sinclair MN,Yin Z,et al.Antagonizing Bcl-2 family members sensitizes neuroblastoma and Ewing′s sarcoma to an inhibitor of glutamine metabolism[J].PloS One,2015,10(1):e0116998. 15 Jeong SM,Lee A,Lee J,et al.SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma[J].J Biol Chem,2014,289(7):4135-4144. 16 Perez-Gomez C,Campos-Sandoval JA,Alonso FJ,et al.Co-expression of glutaminase K and L isoenzymes in human tumour cells[J].Biochem J,2005,386(3):535-542. |